Agenus starts Phase II study of genital herpes treatment; Anti-cocaine vaccine shows promising results in exploratory study;

@AlisonBFierce: U. of Texas at Austin researchers got $6.5M from Dept. of Defense to develop new vaccines for emerging health threats. More | Follow @AlisonBFierce

> Drugstores can give people flu shots, but what about other vaccines? Story

> Genticel announced positive data from a Phase I trial of ProCervix in women infected with high-risk HPV. News

> Sanofi Pasteur filed a Supplemental Biologics License Application with the FDA for a quadrivalent formulation of its Fluzone vaccine. Release

> BiondVax Pharmaceuticals passed an EU quality control audit and will look to develop an oral delivery of its universal flu vaccine. Release

> Agenus ($AGEN) started a Phase II study of its HerpV vaccine for the treatment of genital herpes. Release

And Finally... An anti-cocaine vaccine combined with Immunovaccine's DepoVax showed promising results in an exploratory study. Release

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.